UK Lucentis Biosimilar Nod Offers Teva Potential First-Mover Advantage

Formycon-Bioeq Partnered Ongavia Receives First European Approval In UK

UK red on map of Europe
The UK has given Teva and partner Formycon a first European ranibizumab approval • Source: Shutterstock

More from Biosimilars

More from Products